Insights on patient and HCP engagement, AI, and innovation.

Why ChatGPT and Co-pilot are not safe for pharma and what to use instead

Leading with empathy, with David Henderson at Takeda

RoseRx strengthens AI-first strategy and global expansion with senior leadership appointments

Personalization is not a merge field. I wish it was.

The $35 billion question I kept getting wrong

MLR: the scars are never from caring too much

Agentic AI in pharma: patient & HCP engagement

The opportunities for AI in pharma marketing

Compliance teams lead pharma’s AI transformation

You have invested in AI for clinical trials. What about commercialization?

The new way of working: from static campaigns to dynamic conversations

Pharma’s digital delay is costing patients outcome

The reality of AI in Australia

AI in Australian pharmaceutical marketing: opportunities, risks and readiness

How AI-driven patient engagement platforms are transforming pharma marketing in 2026

How AI is revolutionizing the pharmaceutical sales rep role

AI-powered agents transforming HCP engagement in US pharma

Scaling HCP engagement: smarter, cost-efficient strategies

From crawl to run: the reality of AI implementation in pharma with Arthur Alston

Human readiness: The Key to unlocking AI’s potential

Managing risk in AI adoption

Pharma’s next era: digital transformation & AI insight

Preparing for an AI-first future in life sciences

From awareness to action: How RoseRx helps patients find the right care, faster

AI in healthcare Australia: why doing nothing is the biggest risk

AI & privacy in healthcare: understanding the red line

AI in pharma: 3 focus areas shaping the new era

Generative AI in pharma: how marketing is evolving

Top pharma engagement trends shaping 2026

Patient engagement: measuring digital awareness success

How AI redefines ROI in healthcare communication

Next best action: why it matters for pharma engagement

Pharma’s AI Opportunity: Innovation in Digital Engagement

Why RoseRx is leading the Australian pharma digital-engagement revolution in 2026

Future pharma: RoseRx podcast on AI innovation

How pharma's direct-to-consumer shift is transforming healthcare